Wird geladen...
Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis
Alemtuzumab is a highly efficacious therapy used in the treatment of multiple sclerosis (MS), but uncoupling of T and B cell repopulation during immune reconstitution associates with an increasing range of secondary B cell-mediated autoimmune complications. A 34-year-old woman developed Graves’ dise...
Gespeichert in:
| Veröffentlicht in: | BMJ Case Rep |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5728240/ https://ncbi.nlm.nih.gov/pubmed/29212866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-223016 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|